Gallbladder carcinoma
Updates to Article Attributes
Gallbladder carcinomas are usually asymptomatic until they reach an incurable stage. As such, early incidental detection is important, if the occasional patient is to be successfully treated. The majority (90%) are adenocarcinomas, and the remainder is squamous cell carcinomas.
Epidemiology
Although overall uncommon, gallbladder adenocarcinoma is the most common primary biliary carcinoma and the 5th most common malignancy of the gastrointestinal tract 1.
Predominantly affects older persons with long-standing cholecystolithiasis, and as such is most common in elderly women (>60 years of age, F:M ratio = 4:1) 1,3.
Clinical presentation
Early in the course of the disease, patients are invariably asymptomatic, and as such a therapeutic window is usually missed. Eventually, symptoms develop, at which time the mass is usually not resectable.
Clinical presentation depends on the direction in which the mass extends. In cases where the biliary obstruction is created then jaundice is often the first presentation. If the malignancy is located in the body or fundus of the gallbladder, then extension into the liver or adjacent colon or small bowel can lead to local pain or bowel obstruction respectively.
Other symptoms include right upper quadrant pain, weight loss and anorexia.
Pathology
Over 90% of cases of gallbladder cancer are adenocarcinomas, with the majority related to chronic inflammatory metaplasia and dysplasia 15. Squamous cell carcinoma accounts for the majority of the remainder.
Risk factors
Risk factors include 1:
- chronic cholecystitis
- gallstones are seen in 70-90% of cases 3,4
- familial adenomatous polyposis syndrome (FAP)
- inflammatory bowel disease (IBD)
- porcelain gallbladder
- gallbladder polyps >1 cm that are sessile and solitary
- primary sclerosing cholangitis 13
- anomalous junction of pancreaticobiliary ducts 16
- certain ethnicities and geographical groups (e.g. Native Americans and Chileans) 16
- chronic infections including the typhoid carrier state 16
- exposure to carcinogens (e.g. lead, cadmium, chromium) 16
- obesity, diabetes, and dietary factors 17
- family history of gallbladder carcinoma 18
Radiographic features
Gallbladder adenocarcinomas present in one of three morphologies:
- intraluminal mass
- diffuse mural thickening
- mass replacing the gallbladder
- presumably the end result of progression from either 1 or 2
- most common presentation
Gallstones are commonly present (60%–90%) 14.
CT
Typically gallbladder adenocarcinomas appear as large heterogeneous masses, which may have engulfed gallstones or areas of necrosis. Patchy moderate contrast enhancement is usually seen.
Features of advanced disease include:
- intrahepatic biliary dilatation
- invasion of adjacent structures
- lymphadenopathy
- peritoneal carcinomatosis
- hepatic and other distant metastases
MRI
Dynamic MRI is considered useful and reliable in the staging of advanced gallbladder cancer. MRI combined with MRCP is sensitive in the detection of obstructive jaundice and liver invasion as well as hepatic and lymph nodal metastasis. It may be more difficult to delineate any invasion into the duodenum or to detect omental metastasis by MRI 6. Reported sensitivity rates for direct hepatic invasion and lymph node invasion on MRI can be as high as 100% and 92% respectively 7.
Treatment and prognosis
Unfortunately, due to the largelymostly asymptomatic nature of these tumours, the presentation is typically late with the majority of tumours being large, unresectable, with direct extension into adjacent structures or distant metastases present at diagnosis.
Curative resection is only possible for localised early disease, which is usually found incidentally. This is reflected in the dismal prognosis 4:
- 1-year survival: 80%
- 5-year survival: 1-5%
Differential diagnosis
The differential will depend on the growth pattern of the tumour:
- intraluminal masses
- gallbladder polyp: see differentiating benign vs malignant gallbladder polyps
-
gallbladder metastasis
- melanoma is the most frequent 9
- other described primaries include: lung, oesophagus, pancreas, colon, and kidney carcinomas 9
- mural thickening has a limited differential but is difficult to distinguish on imaging alone, possibilities include
- cholecystitis
- gallbladder wall thickening due to portal hypertension
- adenomyomatosis
- gallbladder tuberculosis 11
- porcelain gallbladder 12
- large tumours differentials include a number of nearby primaries with extension to the gallbladder
- hepatocellular carcinoma (HCC)
- tumours from adjacent organs (pancreas, duodenum) invading gallbladder fossa 10
-</ul><h5>MRI</h5><p>Dynamic MRI is considered useful and reliable in the staging of advanced gallbladder cancer. MRI combined with MRCP is sensitive in detection of obstructive jaundice and liver invasion as well as hepatic and lymph nodal metastasis. It may be more difficult to delineate any invasion into the duodenum or to detect omental metastasis by MRI <sup>6</sup>. Reported sensitivity rates for direct hepatic invasion and lymph node invasion on MRI can be as high as 100% and 92% respectively <sup>7</sup>.</p><h4>Treatment and prognosis</h4><p>Unfortunately, due to the largely asymptomatic nature of these tumours, the presentation is typically late with the majority of tumours being large, unresectable, with direct extension into adjacent structures or distant metastases present at diagnosis.</p><p>Curative resection is only possible for localised early disease, which is usually found incidentally. This is reflected in the dismal prognosis <sup>4</sup>:</p><ul>- +</ul><h5>MRI</h5><p>Dynamic MRI is considered useful and reliable in the staging of advanced gallbladder cancer. MRI combined with MRCP is sensitive in the detection of obstructive jaundice and liver invasion as well as hepatic and lymph nodal metastasis. It may be more difficult to delineate any invasion into the duodenum or to detect omental metastasis by MRI <sup>6</sup>. Reported sensitivity rates for direct hepatic invasion and lymph node invasion on MRI can be as high as 100% and 92% respectively <sup>7</sup>.</p><h4>Treatment and prognosis</h4><p>Unfortunately, due to the mostly asymptomatic nature of these tumours, the presentation is typically late with the majority of tumours being large, unresectable, with direct extension into adjacent structures or distant metastases present at diagnosis.</p><p>Curative resection is only possible for localised early disease, which is usually found incidentally. This is reflected in the dismal prognosis <sup>4</sup>:</p><ul>